Loraz and Besremi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Loraz (lorazepam) and Besremi (ropeginterferon alfa-2b-njft). Common drug interactions include alopecia among females and headache among males.
The phase IV clinical study analyzes what interactions people have when they take Loraz and Besremi. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Loraz?
Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,692 Loraz users. Check the latest studies of Loraz.
What is Besremi?
Besremi has active ingredients of ropeginterferon alfa-2b-njft. eHealthMe is studying from 2,586 Besremi users. Check the latest studies of Besremi.
21 people who take Loraz and Besremi together, and have interactions are studied.
What are the common drug interactions of Loraz and Besremi, by gender? *:
female:
- Alopecia (absence of hair from areas of the body)
- Appetite disorder (abnormal eating habits)
- Headache (pain in head)
- Heart rate increased
- Hypertension (high blood pressure)
- Injection site irritation
- Injection site rash
- Intervertebral disc disorder (spinal disc disorder)
- Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
- Pruritus (severe itching of the skin)
male:
- Headache (pain in head)
- Injection site discolouration
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Sinus congestion (blockage of sinus)
- Platelet count increased
- Platelet count decreased
- White blood cell count decreased
- Arthralgia (joint pain)
- Cough
- Dacryostenosis acquired (obstruction of the nasolacrimal duct-acquired)
What are the existing conditions these people have? *
- Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 21 people, 100.00%
- Sleep Disorder: 3 people, 14.29%
- High Blood Cholesterol: 3 people, 14.29%
- Blood Pressure Abnormal: 3 people, 14.29%
- Nausea (feeling of having an urge to vomit): 2 people, 9.52%
* Approximation only. Some reports may have incomplete information.
Do you take Loraz and Besremi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Loraz and Besremi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Loraz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Besremi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Loraz and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Besremi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lorazepam and ropeginterferon alfa-2b-njft (the active ingredients of Loraz and Besremi, respectively), and Loraz and Besremi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Proventil cause Nodule? - 5 seconds ago
- Trimipramine Maleate vs. Adderall, side effect and effectiveness comparison - 6 seconds ago
- Streptococcal Sepsis and drugs of ingredients of losartan potassium - 21 seconds ago
- Could Peridex cause Fibromyalgia? - 32 seconds ago
- Clarithromycin and Budesonide drug interactions for women aged 50-59 - 33 seconds ago
- Oedema Peripheral and drugs of ingredients of romidepsin - 34 seconds ago
- Could Metformin cause Perivascular Dermatitis? - 37 seconds ago
- Drug interactions of Pantethine and Ursodeoxycholic Acid - 51 seconds ago
- Depakote and Uti for Men aged 40-49 - 54 seconds ago
- Depakote and Cystitis for Men aged 40-49 - 55 seconds ago